Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Mingjun Yu; Yixue Xue; Jian Zheng; Xiaobai Liu; Hai Yu; Libo Liu; Zhen Li; Yunhui Liu

doi:10.1186/s12943-022-01660-3

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Mol Cancer. 2022 Sep 29;21(1):188. doi: 10.1186/s12943-022-01660-3.

Authors

Mingjun Yu^{1

2

3}, Yixue Xue^{4

5

6}, Jian Zheng^{1

2

3}, Xiaobai Liu^{1

2

3}, Hai Yu^{1

2

3}, Libo Liu^{4

5

6}, Zhen Li^{1

2

3}, Yunhui Liu^{7

8

9}

Affiliations

¹ Department of Neurosurgery, Shengjing Hospital of China Medical University, 110004, Shenyang, People's Republic of China.
² Liaoning Clinical Medical Research Center in Nervous System Disease, 110004, Shenyang, People's Republic of China.
³ Key Laboratory of Neuro-oncology in Liaoning Province, 110004, Shenyang, People's Republic of China.
⁴ Department of Neurobiology, College of Basic Medicine, China Medical University, 110122, Shenyang, People's Republic of China.
⁵ Key Laboratory of Cell Biology, Ministry of Public Health of China, China Medical University, 110122, Shenyang, People's Republic of China.
⁶ Key Laboratory of Medical Cell Biology, Ministry of Education of China, China Medical University, 110122, Shenyang, People's Republic of China.
⁷ Department of Neurosurgery, Shengjing Hospital of China Medical University, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.
⁸ Liaoning Clinical Medical Research Center in Nervous System Disease, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.
⁹ Key Laboratory of Neuro-oncology in Liaoning Province, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.

No abstract available

Publication types

Retraction of Publication